Technology
Big cannabinoids, small package.
The cannabinoid sits inside an organogel nanoparticle carrier, protecting it from oxidation and degradation over time. Supplied in bulk to formulate with, or already carried in a hydrogel base. Every batch is characterised and documented.
What we make.
Both products contain the same particles. One is supplied in bulk undiluted form; the other is pre-formulated into a versatile hydrogel carrier. All natural, biologically derived ingredients.
Routes of administration
What it unlocks
Once a cannabinoid is water soluble and under 20 nm, the delivery routes once closed are now opened.
Beverages, syrups, capsules
Goes into water directly, with no emulsifier or co-solvent added at the blending stage. A drink stays clear and the dose stays uniform from the first pour to the last.
Serums and emulsion-free actives
Water-compatible and optically transparent, so it can go into a clear serum or gel without clouding it or needing an oil phase.
Through the skin, or held on it
At this size the particle can cross the epidermis rapidly for direct absorption into blood. How far and how fast is a formulation choice: the hydrogel can be tuned to drive the dose through for systemic uptake, or to hold it at the surface for slower, local release.
Nebulized inhalation
An aqueous suspension can be run through a standard nebulizer. There is no carrier oil to aerosolize, which is the usual obstacle for a lipophilic compound.
Nasal and olfactory
Fine enough to deposit on nasal mucosa, which is densely vascular and absorbs without passing through the gut. The olfactory region is the route studied for direct access to the central nervous system.
First-pass circumvention
Transdermal, nasal and pulmonary routes reach circulation without passing through the liver, so they avoid hepatic first-pass metabolism. Oral doses still pass through it, though lymphatic uptake of a particle this small reduces how much is lost.